Prophylactic use of deferiprone (L1) and magnetic resonance imaging T2* or T2 for preventing heart disease in thalassaemia.
Kolnagou
Annita
A
Fessas
Charis
C
Papatryphonas
Antonis
A
Economides
Charalambos
C
Kontoghiorghes
George J
GJ
D009202:Cardiomyopathies / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D000077543:Deferiprone; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage*; D008279:Magnetic Resonance Imaging; D009206:Myocardium / Q000378:metabolism; D011728:Pyridones / Q000008:administration & dosage*; D013789:Thalassemia / Q000150:complications / Q000378:metabolism
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone